Renoprotective action of l-carnitine in fructose-induced metabolic syndrome
P. Rajasekar
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Tamil Nadu, India
Search for more papers by this authorP. Viswanathan
Department of Pathology, Rajah Muthiah Medical College, Annamalai University, Tamil Nadu, India
Search for more papers by this authorCorresponding Author
C. V. Anuradha
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Tamil Nadu, India
Prof. Dr C. V. Anuradha, Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar-608 002, Tamil Nadu, India.E-mail:cvaradha@hotmail.comSearch for more papers by this authorP. Rajasekar
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Tamil Nadu, India
Search for more papers by this authorP. Viswanathan
Department of Pathology, Rajah Muthiah Medical College, Annamalai University, Tamil Nadu, India
Search for more papers by this authorCorresponding Author
C. V. Anuradha
Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Tamil Nadu, India
Prof. Dr C. V. Anuradha, Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar-608 002, Tamil Nadu, India.E-mail:cvaradha@hotmail.comSearch for more papers by this authorAbstract
Aim: Rats fed high dosage of fructose that form a well-known experimental model of the metabolic syndrome also display progressive renal disturbances. The present study evaluates the influence of l-carnitine (CA) administration on oxidant–antioxidant balance, protein damage and lipid levels in kidney of rats administered high dose of fructose.
Methods: Adult male Wistar rats were divided into four groups of 10 rats each. Groups I and IV animals received starch-based control diet, while groups II and III rats were fed a high-fructose diet (60 g/100 g). Groups III and IV animals additionally received CA (300 mg/kg/day) for 60 days. The extent of lipid peroxidation, enzymatic and non-enzymatic antioxidants and lipid levels were measured after 60 days. The accumulation of nitrated and oxidatively modified proteins in kidney was also measured by immunohistochemical study with specific antibodies.
Results: Fructose-fed rats exhibited increased levels of peroxidation end products, diminished antioxidant status, increased staining for the presence of 4-hydroxy-2-nonenal, 2,4-dinitrophenol and 3-nitrotyrosine protein adducts and lipid accumulation in kidney. CA administration attenuated these pathological renal alterations.
Conclusions: The benefits of CA in this model suggest the therapeutic use of CA to counter the kidney changes associated with metabolic syndrome.
References
- 1 Zavaroni I, Sander S, Scott S, Reaven GM. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 1980; 29: 970–973.
- 2 Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10: 512–516.
- 3 Rajasekar P, Kaviarasan S, Anuradha CV. L-carnitine administration prevents oxidative stress in high fructose-fed insulin resistant rats. Diabetol Croat 2005; 34: 21–28.
- 4 Reaven GM. Syndrome X: 6 years later. J Intern Med 1994; 736: 13–22.
- 5 Faure P, Rossini E, Lafond JL, Richard MJ, Favier A, Halimi S. Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr 1997; 127: 103–107.
- 6 Sanchez-Lozada LG, Tapia E, Jimenez A et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 2007; 292: F423–F429.
- 7 Vasdev S, Ford CA, Longerich L, Gadag V, Wadhawan S. Role of aldehydes in fructose induced hypertension. Mol Cell Biochem 1998; 181: 1–9.
- 8 Kizhner T, Werman MJ. Long-term fructose intake: biochemical consequences and altered renal histology in the male rat. Metabolism 2002; 51: 1538–1547.
- 9 Gulcin I. Antioxidant and antiradical activities of L-carnitine. Life Sci 2006; 78: 803–811.
- 10 Joel D, Kopple JD, Ding H et al. L-carnitine ameliorates gentamicin-induced renal injury in rats. Nephrol Dial Transplant 2002; 17: 2122–2131.
- 11 Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M. L-carnitine inhibits cisplatin induced injury of the kidney and small intestine. Arch Biochem Biophys 2002; 405: 55–64.
- 12 Mathews DR, Hosker JP, Rudenkl AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cells function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
- 13 Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497–509.
- 14 Zlatkis A, Zak B, Boyle AJ. A new method for the direct determination of serum cholesterol. J Lab Clin Med 1953; 41: 486–492.
- 15 Zilversmit DB, Davis AK. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med 1950; 35: 155–160.
- 16 Foster LB, Dunn RT. Stable reagents for determination of serum triglycerides by a colorimetric Hantzsch condensation method. Clin Chem 1973; 19: 338–340.
- 17 Falholt K, Lund B, Falholt W. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta 1973; 46: 105–111.
- 18 Anitha Nandhini AT, Balakrishnan SD, Anuradha CV. Taurine modulates antioxidant potential and controls lipid peroxidation in the aorta of high fructose-fed rats. J Biochem Mol Biol Biophys 2002; 6: 129–133.
- 19 Levine RL, Garland D, Oliver CN et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464–478.
- 20 Dillard CJ, Tappel AL. Fluorescent damage products of lipid peroxidation. Methods Enzymol 1974; 105: 337–341.
- 21 Balakrishnan SD, Anuradha CV. Taurine supplementation attenuates erythrocyte lipid peroxidation in fructose-fed hypertensive rats. Med Sci Res 1999; 27: 489–492.
- 22 Shinozaki K, Nishio Y, Okamura T et al. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ Res 2000; 87: 566–573.
- 23
Suzuki K,
Islam KN,
Kaneto H,
Ookawara T,
Taniguchi N.
The contribution of fructose and nitric oxide to oxidative stress in hamster islet tumor (HIT) cells through the inactivation of glutathione peroxidase.
Electrophoresis
2000; 21: 285–288.
10.1002/(SICI)1522-2683(20000101)21:2<285::AID-ELPS285>3.0.CO;2-5 CASPubMedWeb of Science®Google Scholar
- 24 Fields M, Lewis CG, Lure M, Antholine WE. The influence of gender on developing copper deficiency and on free radical generation of rats fed a fructose diet. Metabolism 1992; 41: 989–994.
- 25 Ookawara T, Kawamura N, Kitagawa Y, Taniguchi N. Site-specific and random fragmentation of Cu, Zn- superoxide dismutase by glycation reaction. Implication of reactive oxygen species. J Biol Chem 1992; 267: 18505–18510.
- 26 Cavarape A, Feletto F, Mercuri F, Quagliaro L, Daman G, Ceriello A. High-fructose diet decreases catalase mRNA levels in rat tissues. J Endocrinol Invest 2001; 24: 838–845.
- 27 Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci U S A 1994; 91: 2616–2620.
- 28 Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003; 42: 318–343.
- 29 Szweda LI, Uchida K, Tsai L, Stadtman ER. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Selective modification of an active-site lysine. J Biol Chem 1993; 268: 3342–3347.
- 30 Vander Jagt DL, Hunsaker LA, Vander Jagt TJ et al. Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem Pharmacol 1997; 53: 1133–1140.
- 31 Davis DW, Hamilton RF Jr, Holian A. 4-Hydroxynonenal inhibits interleukin-1 beta converting enzyme. J Interferon Cytokine Res 1997; 17: 205–210.
- 32 Del Corso A, Dal Monte M, Vilardo PG et al. Site-specific inactivation of aldose reductase by 4-hydroxynonenal. Arch Biochem Biophys 1998; 350: 245–248.
- 33 Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 2003; 140–141: 105–112.
- 34 Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998; 356: 1–11.
- 35 Castro L, Eiserich JP, Sweeney S, Radi R, Freeman BA. Cytochrome c: a catalyst and target of nitrite-hydrogen peroxide-dependent protein nitration. Arch Biochem Biophys 2004; 421: 99–107.
- 36 Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes: new prospect for prevention of diabetic complications? Diabetes Care 1991; 14: 68–72.
- 37 Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV. Effect of α-lipoic acid on lipid profile in rats fed a high-fructose diet. Exp Diabetes Res 2004; 5: 195–200.
- 38 Rajasekar P, Ravichandran MK, Anuradha CV. Intraperitoneal L-carnitine regulates lipid metabolism and reduces oxidative stress in fructose-induced hyperlipidemic rats. Diabetol Croat 2006; 34: 87–95.
- 39 Bakker SJ, IJzerman RG, Teerlink T, Westerhoff HV, Gans RO, Heine RJ. Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure? Atherosclerosis 2000; 148: 17–21.
- 40 Khasigov PZ, Khasanbaeva GSh, Rubachev PG, Nikolaev AIa, Grachev SV. Basal membrane proteins. Biokhimiia 1996; 7: 1152–1168.
- 41 Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992; 15: 1835–1843.
- 42 Reznick AZ, Kagan VE, Ramsey R et al. Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation. Arch Biochem Biophys 1992; 296: 394–401.
- 43 Rajasekar P, Anuradha CV. Fructose-induced hepatic gluconeogenesis: effect of L-carnitine. Life Sci 2007; 80: 1176–1183.
- 44 Virmani A, Gaetani F, Imam S, Binienda Z, Ali S. Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity. Ann N Y Acad Sci 2003; 993: 197–207.
